Lexicon Pharmaceuticals
LXRX
$1.77
Share price
-3.80%
Change (1 day)
-41.20%
Change (1 year)
Categories
Market capitalization of Lexicon Pharmaceuticals (LXRX)
Market cap: $0.63 Billion
As of May 2024 Lexicon Pharmaceuticals has a market cap of $0.63 Billion. This makes Lexicon Pharmaceuticals the world's 5758th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Lexicon Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.63 B | 70.74% |
| 2023 | $0.37 B | 3.96% |
| 2022 | $0.36 B | -38.55% |
| 2021 | $0.58 B | 21.23% |
| 2020 | $0.48 B | 9.72% |
| 2019 | $0.44 B | -37.3% |
| 2018 | $0.70 B | -32.58% |
| 2017 | $1.04 B | -27.5% |
| 2016 | $1.43 B | 4.32% |
| 2015 | $1.37 B | 109.26% |
| 2014 | $0.65 B | -28.66% |
| 2013 | $0.92 B | -18.41% |
| 2012 | $1.13 B | 159.95% |
| 2011 | $0.43 B | -10.35% |
| 2010 | $0.48 B | 62.66% |
| 2009 | $0.29 B | 55.97% |
| 2008 | $0.19 B | -53.79% |
| 2007 | $0.41 B | 47.57% |
| 2006 | $0.28 B | 19.2% |
| 2005 | $0.23 B | -52.15% |
| 2004 | $0.49 B | 33.06% |
| 2003 | $0.37 B | 49.4% |
| 2002 | $0.24 B | -58.74% |
| 2001 | $0.60 B |
End of Day market cap according to different sources
On May 19th, 2024 the market cap of Lexicon Pharmaceuticals was reported to be:
$0.43 Billion
$0.63 Billion
$0.63 Billion
$0.63 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $227.23 B | 35,414.38% | 🇺🇸 USA |
 Illumina ILMN | $17.69 B | 2,665.29% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $108.23 B | 16,815.86% | 🇺🇸 USA |
 Ultragenyx RARE | $3.48 B | 444.01% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.54 B | 141.62% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.44 B | -30.12% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.75 B | 17.78% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $14.72 B | 2,201.68% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $10.82 M | -98.31% | 🇺🇸 USA |